Health Sector Progress: ICH Membership and Clinical Trials in India
Health Sector Urges Expedited ICH Membership
Health sector advancements call for India to accelerate its path towards becoming a full member of the International Council for Harmonisation (ICH). Dr. Seema Pai, president of the Indian Society for Clinical Research (ISCR), emphasizes that this membership is crucial to improve India's share in global clinical trials, which currently stands at only 8% compared to China's 29%.
Impact on Clinical Trials
To address the regulatory bottlenecks in the health industry, Dr. Pai advocates for:
- Streamlined review processes
- Enhanced digital infrastructure
- Predictable regulatory timelines
By implementing these measures, India can significantly improve its clinical trials landscape and retain more early-stage trials within the country.
Collaboration Among Stakeholders
It is essential for all stakeholders in the health sector to collaborate effectively in this endeavor. This collective effort will pave the way for Indian-generated data to gain wider acceptance and eliminate redundant requirements that hinder progress.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.